Therapy of Herpes Virus Infections in Children
Rapid advances have been achieved in the therapy of herpes virus infections of children over the past 25 years. Following the demonstration that vidarabine was an efficacious treatment for neonatal herpes simplex virus (HSV) infections, herpes simplex encephalitis, and varicella zoster virus (VZV) infections of children, significant advances were achieved with the development of second generation anti-viral drugs. The second generation anti-viral drug, namely acyclovir, and, subsequently, valacyclovir and famciclovir, now provide both efficacious as well as safe anti-viral therapy for a variety of herpes virus infections. More recently, the demonstration that ganciclovir proved efficacious for the treatment of congenital cytomegalovirus (CMV) infections provides impetus for improving therapeutics for the most common congenital infection of humans. The therapeutic advances achieved in the management of neonatal HSV infection, herpes simplex encephalitis, VZV infections of the normal and immunocompromised host, and congenital CMV infection will be summarized in this review.
KeywordsHerpes Simplex Virus Central Nervous System Disease Genital Herpes Herpes Simplex Virus Infection Herpes Simplex Encephalitis
Unable to display preview. Download preview PDF.
- American Academy of Pediatrics. (2003). Herpes simplex. In Pickering LK (eds.), Red Book: Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL, American Academy of Pediatrics, pp. 344–353.Google Scholar
- Corey L, and Wald A. (1999). Genital herpes. In Wasserheit JN, (eds.), Sexually Transmitted Diseases, third edn. McGraw-Hill, New York, NY, pp. 285–312.Google Scholar
- Demmler GJ. (1990). Infectious Diseases Society of America and Centers for Disease Control: summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis, 13:315–329.Google Scholar
- Kimura H, Ito Y, Futamura M, et al. (2002). Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Clin Virol, 67:349–353.Google Scholar
- Lakeman FD, Whitley RJ, for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (1995). Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain biopsied patients and correlation with disease. J Infect Dis, 172: 857–863.Google Scholar
- Longson M. (1984). The general nature of viral encephalitis in the United Kingdom. In Ellis LS (eds.), Viral Diseases of the Central Nervous System. Bailliere Tindall, London, pp. 19–31.Google Scholar
- Oliver S, Cloud G, Sánchez P, Demmler G, Dankner W, Shelton M, Jacobs R, Vaudry W, Pass R, Soong S, Whitley R, and Kimberlin D. (2006). Effect of Ganciclovir (GCV) Therapy on Neurodevelopmental Outcomes in Symptomatic Congenital Cytomegalovirus (CMV) Infections Involving the Central Nervous System(CNS): A Randomized, Controlled Study. Society for Pediatric Research (SPR). San Francisco, CA, April 29, Abstract #752908.Google Scholar
- Pass RF. (2001). Cytomegalovirus. In Knipe DM, and Howley PM (eds): Fields Virology (ed 4). Lippincott Williams & Wilkins, Philadelphia, PA, pp. 2675–2705.Google Scholar
- Schlesinger Y, Storch GA. (1994). Herpes simplex meningitis in infancy. Pediatr Infect Dis, 13:141–144.Google Scholar
- Whitley RMD, Davis E Pharm D, MS, and Suppapanya N. Incidence of neonatal herpes simplex virus infections in a managed-care population. Submitted to American Journal of Public Health.Google Scholar